Great Valley Advisor Group, Inc. Bluebird Bio, Inc. Transaction History
Great Valley Advisor Group, Inc.
- $3.21 Billion
- Q1 2024
A detailed history of Great Valley Advisor Group, Inc. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 12,000 shares of BLUE stock, worth $11,040. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,000Holding current value
$11,040% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BLUE
# of Institutions
173Shares Held
104MCall Options Held
827KPut Options Held
1.23M-
Black Rock Inc. New York, NY15.2MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$9.66 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA7.71MShares$7.09 Million0.35% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$5.88 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.24MShares$5.74 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $71M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...